Patented Medicine Prices Review Board Rules of Practice and Procedure, SOR/2012-247

Section 23

Purpose

Cite as Patented Medicine Prices Review Board Rules of Practice and Procedure, SOR/2012-247, s. 23 · current to July 24, 2025 · regulation last amended June 30, 2021

Statute Watch

Get an alert when a bill in Parliament would change this section, and every time it moves.

The text

(1) The parties must appear before the Board at the date, time and place fixed by the Board for a pre-hearing conference for the purpose of (a) identifying or circumscribing the issues; (b) allowing the Board to receive and consider representations referred to in subsection 86(1) of the Act and determine whether the hearing will be held in private; and (c) resolving any other issue that may facilitate the conduct of the hearing. (2) The Board may direct that issues referred to in subsection (1) be addressed during a teleconference with the parties or in written submissions to be filed with the Secretary in any manner that the Board may determine. (3) The Board may require any party who participates in the pre-hearing conference to file and serve, at any time before or during the pre-hearing conference and in any manner that the Board may determine, a written submission setting out any information that the Board considers necessary to expedite the proceeding, including a concise statement of any procedural issues or questions on the merits that the party intends to raise at the hearing. (4) The Board may, if necessary, postpone, suspend or adjourn and may reconvene a pre-hearing conference on any conditions that the Board considers appropriate.
Read the Patented Medicine Prices Review Board Rules of Practice and Procedure on the Justice Laws Website ↗

Made under Patent Act, R.S.C. 1985, c. P-4.

Bills in Parliament that would change this section 0

No bill we hold would amend or repeal this section.